# Does Supplementing of Quadriceps Strength With Exoskeleton After Total Knee Arthroplasty in High Risk Population Reduce Transfer to Extended Care Facility (ECF)

> **NCT03762603** · NA · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Primary Knee Replacement Surgery

## Interventions

- **DEVICE:** Robotic exoskeleton device

## Key facts

- **NCT ID:** NCT03762603
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-09
- **Primary completion:** 2025-12-20
- **Final completion:** 2027-12-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no funding
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03762603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03762603, "Does Supplementing of Quadriceps Strength With Exoskeleton After Total Knee Arthroplasty in High Risk Population Reduce Transfer to Extended Care Facility (ECF)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03762603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*